Vaccine Injury Table
Vaccine | Illness, disability, injury or condition covered | Time period for first symptom or manifestation of onset or of significant aggravation after vaccine administration |
I. Vaccines containing tetanus toxoid (e.g., DTaP, DTP, DT, Td, or TT) | A. Anaphylaxis B. Brachial Neuritis | [LESS THAN EQUAL TO]4 hours. 2-28 days (not less than 2 days and not more than 28 days). |
C. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. | |
D. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
II. Vaccines containing whole cell pertussis bacteria, extracted or partial cell pertussis bacteria, or specific pertussis antigen(s) (e.g., DTP, DTaP, P, DTP-Hib) | A. Anaphylaxis | [LESS THAN EQUAL TO]4 hours. |
B. Encephalopathy or encephalitis | [LESS THAN EQUAL TO]72 hours. | |
C. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. | |
D. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
III. Vaccines containing measles, mumps, and rubella virus or any of its components (e.g., MMR, MM, MMRV) | A. Anaphylaxis B. Encephalopathy or encephalitis | [LESS THAN EQUAL TO]4 hours. 5-15 days (not less than 5 days and not more than 15 days). |
C. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. | |
D. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
IV. Vaccines containing rubella virus (e.g., MMR, MMRV) | A. Chronic arthritis | 7-42 days (not less than 7 days and not more than 42 days). |
V. Vaccines containing measles virus (e.g., MMR, MM, MMRV) | A. Thrombocytopenic purpura | 7-30 days (not less than 7 days and not more than 30 days). |
B. Vaccine-Strain Measles Viral Disease in an immunodeficient recipient | ||
-Vaccine-strain virus identified | Not applicable. | |
-If strain determination is not done or if laboratory testing is inconclusive | [LESS THAN EQUAL TO]12 months. | |
VI. Vaccines containing polio live virus (OPV) | A. Paralytic Polio | |
-in a non-immunodeficient recipient | [LESS THAN EQUAL TO]30 days. | |
-in an immunodeficient recipient | [LESS THAN EQUAL TO]6 months. | |
-in a vaccine associated community case | Not applicable. | |
B. Vaccine-Strain Polio Viral Infection | ||
-in a non-immunodeficient recipient | [LESS THAN EQUAL TO]30 days. | |
-in an immunodeficient recipient | [LESS THAN EQUAL TO]6 months. | |
-in a vaccine associated community case | Not applicable. | |
VII. Vaccines containing polio inactivated virus (e.g., IPV) | A. Anaphylaxis | [LESS THAN EQUAL TO]4 hours. |
B. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. | |
C. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
VIII. Hepatitis B vaccines | A. Anaphylaxis | [LESS THAN EQUAL TO]4 hours. |
B. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. | |
C. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
IX. Haemophilus influenzae type b (Hib) vaccines | A. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. |
B. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
X. Varicella vaccines | A. Anaphylaxis | [LESS THAN EQUAL TO]4 hours. |
B. Disseminated varicella vaccine-strain viral disease | ||
-Vaccine-strain virus identified | Not applicable. | |
-If strain determination is not done or if laboratory testing is inconclusive | 7-42 days (not less than 7 days and not more than 42 days). | |
C. Varicella vaccine-strain viral reactivation | Not applicable. | |
D. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. | |
E. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
XI. Rotavirus vaccines | A. Intussusception | 1-21 days (not less than 1 day and not more than 21 days). |
XII. Pneumococcal conjugate vaccines | A. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. |
B. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
XIII. Hepatitis A vaccines | A. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. |
B. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
XIV. Seasonal influenza vaccines | A. Anaphylaxis | [LESS THAN EQUAL TO]4 hours. |
B. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. | |
C. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
D. Guillain-Barre Syndrome | 3-42 days (not less than 3 days and not more than 42 days). | |
XV. Meningococcal vaccines | A. Anaphylaxis | [LESS THAN EQUAL TO]4 hours. |
B. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. | |
C. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
XVI. Human papillomavirus (HPV) vaccines | A. Anaphylaxis | [LESS THAN EQUAL TO]4 hours. |
B. Shoulder Injury Related to Vaccine Administration | [LESS THAN EQUAL TO]48 hours. | |
C. Vasovagal syncope | [LESS THAN EQUAL TO]1 hour. | |
XVII. Any new vaccine recommended by the Centers for Disease Control and Prevention for routine administration to children and/or pregnant women, after publication by the Secretary of a notice of coverage | A. Shoulder Injury Related to Vaccine Administration B. Vasovagal syncope | [LESS THAN EQUAL TO]48 hours. [LESS THAN EQUAL TO]1 hour. |
stabilization at the nadir of symptoms, or subsequent improvement without significant relapse; however, death may occur without a clinical plateau);
42 C.F.R. §100.3